학술논문
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial.
Document Type
Article
Author
Source
Subject
*SODIUM-glucose cotransporters
*MYOCARDIAL infarction
*SODIUM-glucose cotransporter 2 inhibitors
*
*
Language
ISSN
1462-8902
Abstract
The article discusses a study that examined the effects of empagliflozin, a medication used to treat diabetes, on heart function in patients who had a heart attack. The study found that the medication had similar effects on heart function regardless of the patients' blood sugar levels. The results are consistent with previous research showing the benefits of empagliflozin in heart failure patients. However, more research is needed to fully understand the long-term effects of the medication in heart attack patients. The study was funded by a grant and the authors have no conflicts of interest. [Extracted from the article]